<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00737945</url>
  </required_header>
  <id_info>
    <org_study_id>0804</org_study_id>
    <nct_id>NCT00737945</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Endothelial Dysfunction and Coronary Complexity</brief_title>
  <official_title>Incremental Significance of Endothelial Function Assessed by Reactive Hyperemia Peripheral Arterial Tonometry to Improve Risk Stratification in High Risk Patients for Cardiovascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kumamoto University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kumamoto University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators test the additional clinical value of the physiological assessment of
      endothelial function to the morphological assessment of coronary complexity and classical
      risk score in predicting cardiovascular events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators enroll consecutive, stable high risk patients for cardiovascular events.
      The reactive hyperemia peripheral arterial tonometry index (RHI) was measured before coronary
      angiography and coronary lesions were assessed angiographically by SYNTAX Scoring system. The
      investigators all subjects and examined the occurrence of cardiovascular events (CV death,
      non-fatal myocardial infarction and ischemic stroke, unstable angina pectoris,
      hospitalization for HF, coronary revascularization, or non-fatal aortic and peripheral
      vascular disease).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular event</measure>
    <time_frame>Outcome is assessed 1 to 4 years after entry</time_frame>
    <description>Cardiovascular event consists of cardiovascular death, myocardial infarction, unstable angina, ischemic stroke, coronary revascularization, hospitalization for heart failure, aortic disease and peripheral arterial disease.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1000</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Kumamoto University Hospital and Yokohama City University Medical Center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable, high-risk patients with diabetes mellitus, or more than two conventional
             coronary risk factors, who are referred for coronary angiography because of
             angina-like chest symptoms.

        Exclusion Criteria:

          -  An ejection fraction &lt; 50%

          -  Moderate to severe valvular heart disease

          -  Cardiomyopathy

          -  Allergy to latex

          -  Significant endocrine, hepatic, renal, or inflammatory disease

          -  cerebrovascular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kumamoto University Hospital</name>
      <address>
        <city>Kumamoto</city>
        <zip>860-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2008</study_first_submitted>
  <study_first_submitted_qc>August 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2008</study_first_posted>
  <last_update_submitted>August 23, 2017</last_update_submitted>
  <last_update_submitted_qc>August 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kumamoto University</investigator_affiliation>
    <investigator_full_name>Seigo Sugiyama</investigator_full_name>
    <investigator_title>Department of Cardiovascular Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

